Involvement of the dentate nucleus in the pathophysiology of amyotrophic lateral sclerosis: A multi-center and multi-modal neuroimaging study

Amyotrophic Lateral Sclerosis

Brainstem pathology in amyotrophic lateral sclerosis and primary lateral sclerosis: A longitudinal neuroimaging study

Neuroimage Clin.

Bede P, Chipika RH, Finegan E, Li Hi Shing S, Doherty MA, Hengeveld JC, Vajda A, Hutchinson S, Donaghy C, McLaughlin RL, Hardiman O

doi: 10.1016/j.nicl.2019.102054.

Amyotrophic Lateral Sclerosis

New insights into the pathophysiology of fasciculations in amyotrophic lateral sclerosis: An ultrasound study

Clin Neurophysiol.

Vázquez-Costa JF, Campins-Romeu M, Martínez-Payá JJ, Tembl JI, Del Baño-Aledo ME, Ríos-Díaz J, Fornés-Ferrer V, Chumillas MJ, Sevilla T

doi: 10.1016/j.clinph.2018.09.014.

Amyotrophic Lateral Sclerosis

Novel genes associated with amyotrophic lateral sclerosis: diagnostic and clinical implications

Lancet Neurol.

Chia R, Chiò A, Traynor BJ

doi: 10.1016/

Amyotrophic Lateral SclerosisDementia

Diagnostic and Prognostic Biomarkers in Amyotrophic Lateral Sclerosis: Neurofilament Light Chain Levels in Definite Subtypes of Disease

JAMA Neurol.

Gaiani A, Martinelli I, Bello L, Querin G, Puthenparampil M, Ruggero S, Toffanin E, Cagnin A, Briani C, Pegoraro E, Sorarù G

doi: 10.1001/jamaneurol.

Amyotrophic Lateral Sclerosis

Dysregulation of MicroRNAs and Target Genes Networks in Peripheral Blood of Patients With Sporadic Amyotrophic Lateral Sclerosis

Front Mol Neurosci.

Liguori M, Nuzziello N, Introna A, Consiglio A, Licciulli F, D'Errico E, Scarafino A, Distaso E, Simone IL

doi: 10.3389/fnmol.2018.00288.

Amyotrophic Lateral Sclerosis

Cortical correlates of behavioural change in amyotrophic lateral sclerosis

J Neurol Neurosurg Psychiatry.

Consonni M, Cappa SF, Dalla Bella E, Contarino VE, Lauria G

doi: 10.1136/jnnp-2018-318619.

Amyotrophic Lateral Sclerosis

Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial

Lancet Neurol.

Writing Group, Edaravone (MCI-186) ALS 19 Study Group

doi: 10.1016/

Amyotrophic Lateral Sclerosis

Prevalence of potential sports-associated risk factors in Swiss amyotrophic lateral sclerosis patients

Brain Behav.

Feddermann-Demont N, Junge A, Weber KP, Weller M, Dvořák J, Tarnutzer AA

doi: 10.1002/brb3.630.

Amyotrophic Lateral Sclerosis

Serum C-Reactive Protein as a Prognostic Biomarker in Amyotrophic Lateral Sclerosis

JAMA Neurol.

Lunetta C, Lizio A, Maestri E, Sansone VA, Mora G, Miller RG, Appel SH, Chiò A

doi: 10.1001/jamaneurol.

Related content

Brainstem pathology in amyotrophic lateral sclerosis and primary lateral sclerosis: A longitudinal neuroimaging study

New insights into the pathophysiology of fasciculations in amyotrophic lateral sclerosis: An ultrasound study

Novel genes associated with amyotrophic lateral sclerosis: diagnostic and clinical implications

Diagnostic and Prognostic Biomarkers in Amyotrophic Lateral Sclerosis: Neurofilament Light Chain Levels in Definite Subtypes of Disease

Dysregulation of MicroRNAs and Target Genes Networks in Peripheral Blood of Patients With Sporadic Amyotrophic Lateral Sclerosis

Cortical correlates of behavioural change in amyotrophic lateral sclerosis

Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial

Prevalence of potential sports-associated risk factors in Swiss amyotrophic lateral sclerosis patients

Serum C-Reactive Protein as a Prognostic Biomarker in Amyotrophic Lateral Sclerosis